Veriteq, a Vaisala company, has launched the Viewlinc 3.5 continuous monitoring system, which is fully validated for Food and Drug Administration-regulated, GxP-compliant environments.
The Viewlinc system, suitable for all applications where product quality or patient safety is a concern, provides continuous records, 24/7 alarming and automated reporting.
It can be deployed for monitoring temperature, relative humidity, CO2, differential pressure, level and door switches.
Enhancements include faster updates for 1,000+ sensors; fully scalable for large installations, Viewlinc 3.5 provides enhanced performance for applications with multiple and widely distributed locations.
Viewlinc now comes with faster updates to display data and events over previous versions.
Another new feature is advanced alarm scheduling; Viewlinc can assign alarm and notification delivery to specific staff or service providers.
This feature eliminates the messages being sent to personnel or vendors that are not on call for handling alarms, reducing the costs of overtime or after-hours services.
A further enhancement is the 'zone security for customised access' function, whereby viewing users can customise their interface to show only the areas they are responsible for.
This eliminates the clutter of extra data and prevents users from making inadvertent changes to the alarm limits of other zones.
Viewlinc 3.5 provides flexible installation options and deploys to existing Ethernet-wired, Power over Ethernet and WiFi networks.
As Viewlinc runs on the user's own host server, only one server needs to be validated.
All functions are accessible via all popular internet browsers.
Viewlinc's security features allow IT/Viewlinc administrators to add more users via their normal permission-based network access.
The latest version of Viewlinc still ensures gap-free data recording with triple redundancy - point of measurement, host server and automatic data transfers.
Secure and audit-trail capable, Viewlinc is designed to meet compliance requirements for 21 CFR Part 11, CBER, the Joint Commission, AATB, AABB and other life science and technology regulatory and accreditation bodies.
